Torque Teno Virus: A Promising Biomarker in Kidney Transplant Recipients.

Torque Teno Virus anellovirus immunosuppression immunosuppressive therapy infection kidney transplantation

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
15 Jul 2024
Historique:
received: 08 05 2024
revised: 08 07 2024
accepted: 11 07 2024
medline: 27 7 2024
pubmed: 27 7 2024
entrez: 27 7 2024
Statut: epublish

Résumé

Torque Teno Virus (TTV) is a ubiquitous component of the human virome, not associated with any disease. As its load increases when the immune system is compromised, such as in kidney transplant (KT) recipients, TTV load monitoring has been proposed as a method to assess immunosuppression. In this prospective study, TTV load was measured in plasma and urine samples from 42 KT recipients, immediately before KT and in the first 150 days after it. Data obtained suggest that TTV could be a relevant marker for evaluating immune status and could be used as a guide to predict the onset of infectious complications in the follow-up of KT recipients. Since we observed no differences considering distance from transplantation, while we found a changing trend in days before viral infections, we suggest to consider changes over time in the same subjects, irrespective of time distance from transplantation.

Identifiants

pubmed: 39062987
pii: ijms25147744
doi: 10.3390/ijms25147744
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : This work was funded by the European Union's Horizon 2020 research and innovation pro-gramme under grant agreement number 896932 (TTVguideTX project).
ID : 896932
Organisme : European Union's Horizon 2020
ID : 896932

Auteurs

Sara Dal Lago (S)

Nephrology Department, ASST Sette Laghi, University of Insubria, 21100 Varese, Italy.

Paola Brani (P)

Department of Medicine and Technological Innovation, University of Insubria, 21100 Varese, Italy.

Giuseppe Ietto (G)

Department of Medicine and Technological Innovation, University of Insubria, 21100 Varese, Italy.

Daniela Dalla Gasperina (D)

Department of Medicine and Technological Innovation, University of Insubria, 21100 Varese, Italy.

Francesco Gianfagna (F)

Department of Medicine and Surgery, University of Insubria, 21100 Varese, Italy.
Mediterranea Cardiocentro, 80122 Napoli, Italy.

Cristina Giaroni (C)

Department of Medicine and Technological Innovation, University of Insubria, 21100 Varese, Italy.

Annalisa Bosi (A)

Department of Medicine and Surgery, University of Insubria, 21100 Varese, Italy.

Francesca Drago Ferrante (F)

Laboratory of Microbiology, ASST Sette Laghi, 21100 Varese, Italy.

Angelo Genoni (A)

Department of Medicine and Technological Innovation, University of Insubria, 21100 Varese, Italy.

Hafza Zahira Manzoor (HZ)

Department of Medicine and Technological Innovation, University of Insubria, 21100 Varese, Italy.

Andrea Ambrosini (A)

Nephrology Department, ASST Sette Laghi, University of Insubria, 21100 Varese, Italy.

Marco De Cicco (M)

Nephrology Department, ASST Sette Laghi, University of Insubria, 21100 Varese, Italy.

Corradina Dina Quartarone (CD)

Nephrology Department, ASST Sette Laghi, University of Insubria, 21100 Varese, Italy.

Sara Khemara (S)

Nephrology Department, ASST Sette Laghi, University of Insubria, 21100 Varese, Italy.

Giulio Carcano (G)

Department of Medicine and Technological Innovation, University of Insubria, 21100 Varese, Italy.

Fabrizio Maggi (F)

Laboratory of Virology, National Institute for Infectious Diseases L. Spallanzani-IRCCS, 00149 Rome, Italy.

Andreina Baj (A)

Department of Medicine and Technological Innovation, University of Insubria, 21100 Varese, Italy.

Classifications MeSH